Signed into LawFiled Jan 5, 2026
Sponsor: Appropriations Committee on Health and Human Services
Latest Action
Chapter No. 2026-124
Jun 12, 2026
Summary
The bill updates continuing‑education requirements for podiatric doctors and creates a new regulatory scheme for using cellular and tissue‑based products that are not FDA‑approved. It limits use to specific foot‑related procedures, mandates detailed patient disclosures, and sets penalties for violations. The goal is to enable innovative treatments while protecting patients and upholding ethical standards.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when SB 1092 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 1092 freeOr ask your AI assistant about SB 1092 directly:
Add to Claude, ChatGPT or Cursor